绥美凯国内哪里有卖？

It contains three antiviral drugs, namely dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. Its indications are to treat adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV).

In the SINGLE trial, in the 48-week primary analysis, the proportion of patients achieving virological suppression was better in the dolutegravir XxXABC/3TC group than in the FTC/TDF/ETC group, p=0.003. The same treatment difference was observed among subjects defined by baseline HIV RNA levels (or 100,000 copies/ml). The effect of Suimeike in inhibiting the virus is more obvious.

On January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation Trimeq (dolute abalamib tablets) with the new generation integrase inhibitor dolutegravir (DTG) as the core for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

After Suimeikai is launched in China, patients can buy it in some large domestic hospitals with prescriptions issued by doctors, without having to go abroad, which is more convenient. However, as an original drug, the price of Suimeikai is relatively high, which puts many patients under great long-term financial pressure.

Medical Travel understands that Suimeikai is currently on the market in India. It is produced by Emcure. The effect is the same as the original domestic drug. Each box contains 30 tablets. The price is about $1,000, which is much lower than the domestic price. It is a good choice for patients. If it is inconvenient for patients to go abroad, they can also use direct mail through Medical Companion Travel to send medicines directly from Indian pharmacies to patients, and patients do not have to worry about buying counterfeit medicines.

It has been approved for marketing in more than 50 countries around the world, and more and more HIV patients will benefit from it.